Featured Research

from universities, journals, and other organizations

Transplant criteria for liver cancer patients: News standards aim for equitable allocation of available organs

Date:
March 5, 2010
Source:
Wiley - Blackwell
Summary:
Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers. Full details of the recommendations developed at the conference are published in the March issue of Liver Transplantation.

Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers. Full details of the recommendations developed at the conference are published in the March issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases (AASLD).

The National Cancer Institute estimates that more than 16,000 men and over 6,000 women in the U.S. will be diagnosed with liver cancer, and over 18,000 liver cancer patients will succumb to the disease each year (2009). Furthermore, the United Network of Organ Sharing (UNOS) reports as many as 15,000 patients are waiting for liver transplantation, with living and deceased organ donation down by 1.7% and 1.2%, respectively (2008).

"Organs from deceased donors are considered a national resource, therefore their use should be equitable and fair, said James Neuberger, M.D., from Queen Elizabeth Hospital in the U.K and medical director of Organ Donation and Transplantation at NHS Blood and Transplant, in his editorial also published this month in Liver Transplantation. U.S. transplant physicians agree and assembled six work groups at the conference to: standardize pathology reporting, develop specific imaging criteria, expand the Milan Criteria (MC, set of criteria used to measure tumor size to determine if a patient qualifies for LT), discuss locoregional therapy (LRT), define criteria for down-staging transplantation, and review current liver allocation system for HCC patients.

Elizabeth A. Pomfret, M.D., Ph.D., F.A.C.S. from the Lahey Clinic Medical Center in Burlington, MA and her team were responsible for summarizing the recommendations. Dr. Pomfret said, "Ultimately we agreed that the allocation policy should result in similar risks of removal from the waiting list and comparable transplant rates for HCC and non-HCC candidates alike."

At the end of the session, attendees agreed on 9 final recommendations for transplantation of liver cancer patients:

1. Additional priority should be maintained for candidates with HCC who meet MC. No regional adjustment in assigned priority for HCC candidates in this iteration.

2. A calculated continuous HCC priority score should be developed that incorporates calculated model end stage liver disease (MELD) score, alpha-fetoprotein (AFP), tumor size and rate of tumor growth. Only candidates with at least stage T2 tumors will receive additional HCC points.

2.1. Candidates with T1 tumors or tumors outside MC must be designated as having HCC on wait list registrations and/or updates

2.2. A designation for HCC (yes/no) will be captured at registration for all candidates regardless of any requests for priority.

3. The candidate must be within MC for a minimum of 3 months before additional points are assigned.

3.1. Time is calculated from date of the first imaging study indicating that the MC is met if the liver tumor meets Class 5A imaging criteria.

4. Patients with a diagnosis of HCC within MC and a calculated MELD score < 15 will start with a MELD/HCC priority score of 15 until they have had the HCC diagnosis for 3 months, then they will receive the calculated MELD/HCC priority score.

5. Patients with a calculated MELD score > 15 will receive their calculated MELD until the 3 months since the diagnosis of HCC within MC have elapsed, then they will receive their calculated MELD/HCC priority score.

6. MELD/HCC priority score will be recalculated every 3 months and can increase or decrease according to changes in tumor characteristics, underlying MELD score and time within MC.

7. Allocation points will be based on candidate's calculated MELD score PLUS the following factors:

7.1. AFP < 500 ng/ml

7.2. Tumor size within MC

7.3. Time within MC, including patients down-staged to within MC

8. No points will be added if AFP > 500 ng/ml.

9. Patients with elevated AFP and no tumor by imaging will no longer receive additional MELD points

"The recommendations set forth at the conference are warmly welcomed outside as well as within the U.S.," concluded Dr. Neuberger. "This report should not be the final word, but the first in a series of discussions that refine the role of liver transplantation in the management of patients with liver cancer."


Story Source:

The above story is based on materials provided by Wiley - Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley - Blackwell. "Transplant criteria for liver cancer patients: News standards aim for equitable allocation of available organs." ScienceDaily. ScienceDaily, 5 March 2010. <www.sciencedaily.com/releases/2010/03/100305083310.htm>.
Wiley - Blackwell. (2010, March 5). Transplant criteria for liver cancer patients: News standards aim for equitable allocation of available organs. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/03/100305083310.htm
Wiley - Blackwell. "Transplant criteria for liver cancer patients: News standards aim for equitable allocation of available organs." ScienceDaily. www.sciencedaily.com/releases/2010/03/100305083310.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins